Record #54270
Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Notes from Retraction Watch
see also: https://pubpeer.com/publications/ECAE674D2B96F98DF26BDC250EA222;
Citation lifecycle
How this paper is being cited
Pre-retraction
37
Same day
1
Post-retraction
2
% post-retraction
5.1%
~3.1 citations/yr before retraction · ~0.8 citations/yr after
— citing papers
Who is still citing this work
Loading…